Biomarker Trends in Patients With Immune-Checkpoint Inhibitor Myocarditis

被引：0
|
作者：
Vasbinder, Alexi
Chen, YeeAnn
Gradone, Allison
Azam, Tariq
Perry, Daniel
Shadid, Husam
Anderson, Elizabeth
Catalan, Tonimarie
Blakely, Pennelope
Adie, Sarah
Pogue, Kristen
Leja, Monika
Yentz, Sarah
Schneider, Bryan
Fecher, Leslie
Lao, Christopher D.
Hayek, Salim
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12324
引用
收藏
页数：3
相关论文
共 50 条
  • [1] BIOMARKER TRENDS AND OUTCOMES IN PATIENTS RECEIVING IMMUNE-CHECKPOINT INHIBITORS
    Vasbinder, Alexi
    Chen, YeeAnn
    Gradone, Allison
    Azam, Tariq
    Perry, Daniel
    Shadid, Husam
    Anderson, Elizabeth
    Catalan, Tonimarie
    Blakely, Pennelope K.
    Nelapudi, Namratha
    Fardous, Mohamad
    Adie, Sarah
    Pogue, Kristen
    Leja, Monika Jacqueline
    Yentz, Sarah
    Schneider, Bryan
    Hayek, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2366 - 2366
  • [2] A CASE OF IMMUNE-CHECKPOINT INHIBITOR MYOCARDITIS AND INTERSTITIAL NEPHRITIS
    Godding, Mark J.
    Russell, Raymond R., III
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3598 - 3598
  • [3] Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis
    Vasbinder, Alexi
    Chen, YeeAnn
    Procureur, Adrien
    Gradone, Allison
    Azam, Tariq U.
    Perry, Daniel
    Shadid, Husam
    Anderson, Elizabeth
    Catalan, Tonimarie
    Blakely, Pennelope
    Nelapudi, Namratha
    Fardous, Mohamad
    Bretagne, Marie C.
    Adie, Sarah K.
    Pogue, Kristen T.
    Leja, Monika
    Yentz, Sarah
    Schneider, Bryan
    Fecher, Leslie A.
    Lao, Christopher D.
    Salem, Joe-Elie
    Hayek, Salim S.
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 689 - 700
  • [4] Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
    Vasbinder, Alexi
    Ismail, Anis
    Salem, Joe-Elie
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (09) : 959 - 967
  • [5] Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
    Alexi Vasbinder
    Anis Ismail
    Joe-Elie Salem
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 959 - 967
  • [6] DEVELOPMENT OF A QUANTIFICATION METHOD FOR IMMUNE-CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS
    Kaisar, S.
    Badreldin, Y.
    CYTOTHERAPY, 2024, 26 (06) : E21 - E21
  • [7] Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
    Ben Zadok, Osnat Itzhaki
    Ben-Avraham, Ben
    Nohria, Anju
    Orvin, Katia
    Nassar, Mithal
    Iakobishvili, Zaza
    Neiman, Victoria
    Goldvaser, Hadar
    Kornowski, Ran
    Ben Gal, Tuvia
    JACC: CARDIOONCOLOGY, 2019, 1 (01): : 141 - 144
  • [8] Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis
    Ali, Abdelrahman
    Lu, Yang
    Khalaf, Shaden
    Iliescu, Cezar
    Koutroumpakis, Efstratios
    Yusuf, Syed Wamique
    Siddiqui, Bilal A.
    Subudhi, Sumit K.
    Deswal, Anita
    Palaskas, Nicolas L.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2024, 39
  • [9] Immune-Checkpoint Inhibitor Use in Patients with ESKD
    Kitchlu, Abhijat
    Jhaveri, Kenar D.
    Sprangers, Ben
    Yanagita, Motoko
    Wanchoo, Rimda
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 576 - 577
  • [10] Immune checkpoint inhibitor myocarditis
    Raikhelkar, Jayant
    Uriel, Nir
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (03) : 303 - 306
12345